Patent Foramen Ovale Closure for Treating Migraine: A Meta-Analysis
Background. Observational studies have shown percutaneous patent foramen ovale (PFO) closure to be a safe means of reducing the frequency and duration of migraine. Objective. This study evaluated the efficacy and safety of PFO closure in patients with migraine using evidence-based medicine. Methods....
Saved in:
Main Authors: | Yu Zhang, Haijiao Wang, Ling Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Interventional Cardiology |
Online Access: | http://dx.doi.org/10.1155/2022/6456272 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patent Foramen Ovale and Closure Technique with the Amplatzer Occluder
by: Bernhard Meier
Published: (2014-01-01) -
Symptomatic Patent Foramen Ovale with Hemidiaphragm Paralysis
by: Hussain Ibrahim, et al.
Published: (2017-01-01) -
Comparison of Patent Foramen Ovale Sizing by Transesophageal Echocardiography and Balloon Sizing in Patients Undergoing Percutaneous Closure
by: Birgitte Carbuhn Larsen, MD, et al.
Published: (2025-01-01) -
A Retrospective Analysis of Self-Limiting Fever following Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure
by: Francesca Galasso, et al.
Published: (2024-01-01) -
Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome
by: Joelle Kefer, et al.
Published: (2022-01-01)